Neuronetics Inc Stock Ownership - Who owns Neuronetics?

Insider buying vs selling

Have Neuronetics Inc insiders been buying or selling?
Robert CascellaDirector2024-06-0650,000$2.05
William Andrew MacAnEVP GC CCO and CS2024-02-296,026$2.94
William Andrew MacAnEVP GC CCO and CS2024-02-2822,377$3.16
Stephen FurlongEVP CFO and Treasurer2024-02-283,985$3.16
Stephen FurlongEVP CFO and Treasurer2024-02-2721,272$3.33
Keith J. SullivanPresident and CEO2024-02-2620,292$3.30
Keith J. SullivanPresident and CEO2024-02-2320,750$3.23
Keith J. SullivanPresident and CEO2024-02-2220,851$3.23
Keith J. SullivanPresident and CEO2024-02-2023,958$2.96
William Andrew MacAnEVP GC CCO and CS2024-02-1415,621$3.38

1 of 3

STIM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STIM insiders and whales buy or sell their stock.

STIM Shareholders

What type of owners hold Neuronetics Inc stock?
Cannell Capital LLC18.36%5,508,835$10.08MInsider
Archon Capital Management LLC8.46%2,537,097$4.64MInstitution
Cannell Capital LLC8.21%2,463,256$4.51MInstitution
Investor Growth Capital LLC5.98%1,794,228$3.28MInsider
Ronald Hunt5.15%1,543,962$2.83MInsider
New Leaf Ventures Ii LP5.14%1,543,115$2.82MInsider
Divisadero Street Capital Management LP5.13%1,539,447$2.82MInstitution
Keith J. Sullivan4.57%1,372,278$2.51MInsider
Ge Ventures Ltd4.36%1,308,041$2.39MInsider
Vanguard Group Inc4.33%1,299,915$2.38MInstitution

1 of 3

STIM vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STIM52.51%47.49%Net SellingNet Buying
VNRX9.40%40.20%Net BuyingNet Selling
ENZ26.86%47.90%Net Selling
TTOO0.35%99.65%Net Selling
NOTV25.30%43.46%Net Buying

Neuronetics Stock Ownership FAQ

Who owns Neuronetics?

Neuronetics (NASDAQ: STIM) is owned by 58.96% institutional shareholders, 53.34% Neuronetics insiders, and 0.00% retail investors. Cannell Capital LLC is the largest individual Neuronetics shareholder, owning 5.51M shares representing 18.36% of the company. Cannell Capital LLC's Neuronetics shares are currently valued at $9.75M.

If you're new to stock investing, here's how to buy Neuronetics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.